HCPCS Level II drug code
J2700 — Injection, oxacillin sodium, up to 250 mg
In short
J2700 is the HCPCS Level II code for injection, oxacillin sodium, up to 250 mg. CMS assigns NDCs for Bactocill In Dextrose and Oxacillin Sodium to it. The Medicare Part B payment limit is $0.768 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, oxacillin sodium, up to 250 mg
- Short descriptor
- Oxacillin sodium injeciton
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2014
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J2700
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 14 NDCs to J2700 for Bactocill In Dextrose and Oxacillin Sodium. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Bactocill In Dextrose | 00338-1015-41 | Baxter Healthcare Corporation | 50 | 8 |
| Oxacillin Sodium | 25021-0146-10 | Sagent Pharmaceuticals | 10 × 1 | 40 |
| Oxacillin Sodium | 25021-0162-24 | Sagent Pharmaceuticals | 10 × 1 | 80 |
| Oxacillin Sodium | 25021-0162-68 | Sagent Pharmaceuticals | 10 × 1 | 80 |
| Oxacillin Sodium | 25021-0163-68 | Sagent Pharmaceuticals | 10 × 1 | 400 |
| Oxacillin Sodium | 25021-0163-97 | Sagent Pharmaceuticals | 1 | 40 |
| Oxacillin Sodium | 25021-0163-99 | Sagent Pharmaceuticals | 10 × 1 | 400 |
| Oxacillin Sodium | 55150-0127-15 | Eugia US LLC | 10 × 1 | 40 |
| Oxacillin Sodium | 55150-0128-24 | Eugia US LLC | 10 × 1 | 80 |
| Oxacillin Sodium | 55150-0129-99 | Eugia US LLC | 1 | 40 |
| Oxacillin Sodium | 63323-0811-00 | FreseniUS Kabi USA, LLC | 1 | 40 |
| Oxacillin Sodium | 63323-0812-20 | FreseniUS Kabi USA, LLC | 10 × 1 | 80 |
| Oxacillin Sodium | 63323-0813-20 | FreseniUS Kabi USA, LLC | 10 × 1 | 40 |
| Oxacillin Sodium | 72485-0409-10 | Armas Pharmaceuticals Inc. | 10 × 1 | 80 |
J2700: common questions
- Is J2700 a CPT code?
- No. J2700 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J2700?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 14 NDCs under J2700, for Bactocill In Dextrose and Oxacillin Sodium. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J2700?
- $0.768 per 250 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.